WT
NBRV

Wellcome Trust’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Wellcome Trust’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-54
Closed -$81K – 29
2016
Q4 		$81K Hold
54
– – ﹤0.01% 28
2016
Q3 		$121K Hold
54
– – ﹤0.01% 29
2016
Q2 		$121K Sell
54
-4,712
-99% -$9.49M ﹤0.01% 30
2016
Q1 		$10.7M Sell
4,766
-22
-0.5% -$47.2K 0.24% 26
2015
Q4 		$112M Sell
4,788
-147
-3% -$359K 2.24% 21
2015
Q3 		$11.7M Buy
+4,935
New +$13.1M 0.26% 27

Other funds holding NBRV

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellcome Trust's NBRV Position: Q1 2017 in Review

Wellcome Trust sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q1 2017, closing a stake of 54 shares — an estimated $81K sold.

Wellcome Trust first reported a position in NBRV in Q3 2015 and held it in 6 quarters. The position peaked at $112M in Q4 2015. 24 funds tracked by Wall St. Rank hold NBRV as of Q1 2017.

  • Wellcome Trust reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q1 2017 after selling out during the quarter.
  • Wellcome Trust sold 54 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q1 2017, an estimated $81K.
  • Wellcome Trust first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2015 and held it in 6 quarters.
  • Wellcome Trust's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $112M in Q4 2015.
  • 24 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q1 2017.

Based on Wellcome Trust's 13F filing for Q1 2017, filed 12 Apr 2017.